Wall Street analysts predict that NanoString Technologies, Inc. (NASDAQ:NSTG – Get Rating) will report earnings per share (EPS) of ($0.54) for the current fiscal quarter, Zacks reports. Zero analysts have made estimates for NanoString Technologies’ earnings. The highest EPS estimate is ($0.45) and the lowest is ($0.62). NanoString Technologies posted earnings of ($0.62) per share during the same quarter last year, which suggests a positive year over year growth rate of 12.9%. The company is expected to announce its next quarterly earnings results after the market closes on Monday, January 1st.
On average, analysts expect that NanoString Technologies will report full-year earnings of ($2.19) per share for the current financial year, with EPS estimates ranging from ($2.72) to ($1.61). For the next financial year, analysts forecast that the business will post earnings of ($1.63) per share, with EPS estimates ranging from ($2.17) to ($1.17). Zacks’ earnings per share calculations are an average based on a survey of sell-side research firms that follow NanoString Technologies.
NanoString Technologies (NASDAQ:NSTG – Get Rating) last issued its quarterly earnings data on Tuesday, March 1st. The biotechnology company reported ($0.64) EPS for the quarter, missing analysts’ consensus estimates of ($0.55) by ($0.09). NanoString Technologies had a negative return on equity of 55.40% and a negative net margin of 79.44%. The business had revenue of $42.46 million during the quarter, compared to analysts’ expectations of $41.90 million. During the same period in the previous year, the business earned ($0.53) earnings per share. The business’s quarterly revenue was up 17.1% on a year-over-year basis.
Shares of NASDAQ:NSTG traded down $0.71 on Tuesday, reaching $19.74. The company had a trading volume of 22,831 shares, compared to its average volume of 689,161. The company has a current ratio of 8.20, a quick ratio of 7.60 and a debt-to-equity ratio of 1.27. The firm has a market capitalization of $906.95 million, a PE ratio of -7.73 and a beta of 1.75. The firm’s 50 day simple moving average is $31.31 and its 200-day simple moving average is $37.41. NanoString Technologies has a 52-week low of $19.23 and a 52-week high of $81.89.
In other news, SVP Joseph M. Beechem sold 2,968 shares of the business’s stock in a transaction dated Tuesday, March 8th. The shares were sold at an average price of $33.06, for a total value of $98,122.08. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CFO K Thomas Bailey sold 3,058 shares of the firm’s stock in a transaction on Tuesday, March 8th. The shares were sold at an average price of $33.06, for a total value of $101,097.48. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 33,864 shares of company stock worth $1,054,146. Company insiders own 2.80% of the company’s stock.
A number of hedge funds and other institutional investors have recently bought and sold shares of NSTG. Pinebridge Investments L.P. bought a new position in shares of NanoString Technologies during the 4th quarter valued at approximately $30,000. Dark Forest Capital Management LP boosted its position in NanoString Technologies by 102.7% during the third quarter. Dark Forest Capital Management LP now owns 1,267 shares of the biotechnology company’s stock valued at $61,000 after purchasing an additional 642 shares in the last quarter. Point72 Hong Kong Ltd grew its holdings in NanoString Technologies by 449.7% in the third quarter. Point72 Hong Kong Ltd now owns 1,979 shares of the biotechnology company’s stock worth $95,000 after purchasing an additional 1,619 shares during the last quarter. Advisor Group Holdings Inc. increased its holdings in shares of NanoString Technologies by 15.0% during the fourth quarter. Advisor Group Holdings Inc. now owns 3,795 shares of the biotechnology company’s stock valued at $160,000 after acquiring an additional 496 shares in the last quarter. Finally, Russell Investments Group Ltd. boosted its stake in NanoString Technologies by 33.6% in the 3rd quarter. Russell Investments Group Ltd. now owns 4,400 shares of the biotechnology company’s stock worth $211,000 after purchasing an additional 1,107 shares in the last quarter.
NanoString Technologies Company Profile (Get Rating)
NanoString Technologies, Inc develops, manufactures, and sells tools for scientific and clinical research in the fields of genomics and proteomics in the Americas, Europe, the Middle East, and the Asia Pacific. The company offers nCounter Analysis System, an automated, multi-application, digital detection, and counting system.
- Get a free copy of the StockNews.com research report on NanoString Technologies (NSTG)
- Simpson Manufacturing Co. Hits The Nail On The Head, Again
- The Sherwin-Williams Company Bottoms Above Institutional Support
- What To Make Of Activision Blizzard (NASDAQ: ATVI)
- Whirlpool Is A Steal At These Prices
- Kimberly-Clark Pops On Successful Price Pass-Through
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for NanoString Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NanoString Technologies and related companies with MarketBeat.com's FREE daily email newsletter.